Related references
Note: Only part of the references are listed.Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease
Wei-Qin Zhao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Insulin-degrading enzyme is exported via an unconventional protein secretion pathway
Ji Zhao et al.
MOLECULAR NEURODEGENERATION (2009)
Insulin rescues amyloid β-induced impairment of hippocampal long-term potentiation
Cheng-Che Lee et al.
NEUROBIOLOGY OF AGING (2009)
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Dennis J. Selkoe
BEHAVIOURAL BRAIN RESEARCH (2008)
A beta-degrading enzymes in Alzheimer's disease
James Scott Miners et al.
BRAIN PATHOLOGY (2008)
Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease
Natalia N. Nalivaeva et al.
CURRENT ALZHEIMER RESEARCH (2008)
Neprilysin and amyloid beta peptide degradation
Louis B. Hersh et al.
CURRENT ALZHEIMER RESEARCH (2008)
Amyloid beta oligomers induce impairment of neuronal insulin receptors
Wei-Qin Zhao et al.
FASEB JOURNAL (2008)
Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-β in memory-impaired older adults
Mark A. Reger et al.
JOURNAL OF ALZHEIMERS DISEASE (2008)
Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease
John E. Donahue et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Detergent resistant membrane-associated IDE in brain tissue and cultured cells: Relevance to Aβ and insulin degradation
Ayelen Bulloj et al.
MOLECULAR NEURODEGENERATION (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Intranasal insulin improves cognition and modulates β-amyloid in early AD
M. A. Reger et al.
NEUROLOGY (2008)
Advances on the understanding of the origins of synaptic pathology in AD
Pascale Nathalie Lacor
CURRENT GENOMICS (2007)
Soluble Aβ inhibits specific signal transduction cascades common to the insulin receptor pathway
Matthew Townsend et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced β-cell apoptosis in h-IAPP transgenic mice
Chia-Yu Lin et al.
DIABETES (2007)
Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease
Rashid Deane et al.
CURRENT ALZHEIMER RESEARCH (2007)
Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease
Pascale N. Lacor et al.
JOURNAL OF NEUROSCIENCE (2007)
Monoclonal antibodies that target pathological assemblies of A beta
Mary P. Lambert et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: New cues into the human disease?
Eva Carro et al.
NEUROBIOLOGY OF AGING (2006)
A century-old debate on protein aggregation and neurodegeneration enters the clinic
Peter T. Lansbury et al.
NATURE (2006)
Neprilysin-sensitive synapse-associated amyloid-β peptide oligomers impair neuronal plasticity and cognitive function
Shu-Ming Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
Ward A. Pedersen et al.
EXPERIMENTAL NEUROLOGY (2006)
Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity:: a potent role for trimers
M Townsend et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
Insulin-like growth factor-1 prevents Aβ[25-35]/(H2O2)-induced apoptosis in lymphocytes by reciprocal NF-κB activation and p53 inhibition via PI3K-dependent pathway
MJ Del Rio et al.
GROWTH FACTORS (2006)
Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease:: review and hypothesis
WQ Qiu et al.
NEUROBIOLOGY OF AGING (2006)
Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease
GS Watson et al.
NEUROBIOLOGY OF AGING (2006)
Insulin resistance syndrome and Alzheimer's disease: Age- and obesity-related effects on memory, amyloid, and inflammation
S Craft
NEUROBIOLOGY OF AGING (2005)
Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease
GK Gouras et al.
NEUROBIOLOGY OF AGING (2005)
A role of insulin-like growth factor 1 in β amyloid-induced disinhibition of hippocampal neurons
CH Xing et al.
NEUROSCIENCE LETTERS (2005)
Aβ42 is essential for parenchymal and vascular amyloid deposition in mice
E McGowan et al.
NEURON (2005)
The role of cerebral amyloid β accumulation in common forms of Alzheimer disease
S Gandy
JOURNAL OF CLINICAL INVESTIGATION (2005)
Natural oligomers of the amyloid-protein specifically disrupt cognitive function
JP Cleary et al.
NATURE NEUROSCIENCE (2005)
Insulin and the insulin receptor in experimental models of learning and memory
WQ Zhao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Dimeric amyloid β protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease
T Kawarabayashi et al.
JOURNAL OF NEUROSCIENCE (2004)
Increased risk of type 2 diabetes in Alzheimer disease
J Janson et al.
DIABETES (2004)
Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-β peptide in mouse brain
N Iwata et al.
JOURNAL OF NEUROSCIENCE (2004)
LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms
R Deane et al.
NEURON (2004)
Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: Implications for Alzheimer's disease intervention
LX Zhao et al.
JOURNAL OF NEUROSCIENCE (2004)
Protein aggregation and neurodegenerative disease
CA Ross et al.
NATURE MEDICINE (2004)
Synaptic targeting by Alzheimer's-related amyloid β oligomers
PN Lacor et al.
JOURNAL OF NEUROSCIENCE (2004)
Diabetes due to a progressive defect in β-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat) -: A new model for type 2 diabetes
AE Butler et al.
DIABETES (2004)
Alzheimer's disease-affected brain:: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
YS Gong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Diabetes, Alzheimer's disease and apolipoprotein genotype
C Messier
EXPERIMENTAL GERONTOLOGY (2003)
Differential degradation of amyloid β genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme
L Morelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The role of insulin resistance in the pathogenesis of Alzheimer's disease - Implications for treatment
GS Watson et al.
CNS DRUGS (2003)
Aβ toxicity in Alzheimer's disease:: globular oligomers (ADDLs) as new vaccine and drug targets
WL Klein
NEUROCHEMISTRY INTERNATIONAL (2002)
Alzheimer's disease is a synaptic failure
DJ Selkoe
SCIENCE (2002)
Amyloid-β oligomers:: their production, toxicity and therapeutic inhibition
DM Walsh et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update
S Hoyer
JOURNAL OF NEURAL TRANSMISSION (2002)
Metabolic regulation of brain Aβ by neprilysin
N Iwata et al.
SCIENCE (2001)
Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum?
WL Klein et al.
TRENDS IN NEUROSCIENCES (2001)
Insulin and insulin-like growth factor I receptors: Similarities and differences in signal transduction
J Dupont et al.
HORMONE RESEARCH (2001)
Modulation of amyloid β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway
DE Kang et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Oxidative stress in Alzheimer's disease
MA Smith et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2000)
Share Paper
